[1] Sadick M, Müller-Wille R, Wildgruber M, Wohlgemuth WA. Vascular anomalies (part Ⅰ):classification and diagnostics of vascular anomalies[J]. Rofo, 2018, 190:825-835. [2] Paddock M, Lanham S, Gill K, Sinha S, Connolly DJA. Pediatric cerebral cavernous malformations[J]. Pediatr Neurol, 2021, 116:74-83. [3] Al-Holou WN, O'Lynnger TM, Pandey AS, Gemmete JJ, Thompson BG, Muraszko KM, Garton HJ, Maher CO. Natural history and imaging prevalence of cavernous malformations in children and young adults[J]. J Neurosurg Pediatr, 2012, 9:198-205. [4] Han G, Ma L, Qiao H, Han L, Wu Q, Li Q. A novel CCM2 missense variant caused cerebral cavernous malformations in a Chinese family[J]. Front Neurosci, 2021, 14:604350. [5] Batra S, Lin D, Recinos PF, Zhang J, Rigamonti D. Cavernous malformations:natural history, diagnosis and treatment[J]. Nat Rev Neurol, 2009, 5:659-670. [6] Mahajan UV, Patel M, Pace J, Rothstein BD. Presentation and management of nervous system cavernous malformations in children:a systematic review and case report[J]. Brain Circ, 2022, 8:121-126. [7] Gross BA, Du R. Hemorrhage from cerebral cavernous malformations:a systematic pooled analysis[J]. J Neurosurg, 2017, 126:1079-1087. [8] Washington CW, McCoy KE, Zipfel GJ. Update on the natural history of cavernous malformations and factors predicting aggressive clinical presentation[J]. Neurosurg Focus, 2010, 29:E7. [9] Zafar A, Quadri SA, Farooqui M, Ikram A, Robinson M, Hart BL, Mabray MC, Vigil C, Tang AT, Kahn ML, Yonas H, Lawton MT, Kim H, Morrison L. Familial cerebral cavernous malformations[J]. Stroke, 2019, 50:1294-1301. [10] Riolo G, Ricci C, Battistini S. Molecular genetic features of Cerebral Cavernous Malformations (CCM) patients:an overall view from genes to endothelial cells[J]. Cells, 2021, 10:704. [11] Merello E, Pavanello M, Consales A, Mascelli S, Raso A, Accogli A, Cama A, Valeria C, De Marco P. Genetic screening of pediatric cavernous malformations[J]. J Mol Neurosci, 2016, 60:232-238. [12] Shenkar R, Shi C, Rebeiz T, Stockton RA, McDonald DA, Mikati AG, Zhang L, Austin C, Akers AL, Gallione CJ, Rorrer A, Gunel M, Min W, De Souza JM, Lee C, Marchuk DA, Awad IA. Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutations[J]. Genet Med, 2015, 17:188-196. [13] Gillespie CS, Alnaham KE, Richardson GE, Mustafa MA, Taweel BA, Islim AI, Hannan CJ, Chavredakis E. Predictors of future haemorrhage from cerebral cavernous malformations:a retrospective cohort study[J]. Neurosurg Rev, 2023, 46:52. [14] Moore SA, Brown RD Jr, Christianson TJ, Flemming KD. Long-term natural history of incidentally discovered cavernous malformations in a single-center cohort[J]. J Neurosurg, 2014, 120:1188-1192. [15] Gross BA, Du R, Orbach DB, Scott RM, Smith ER. The natural history of cerebral cavernous malformations in children[J]. J Neurosurg Pediatr, 2016, 17:123-128. [16] Santos AN, Rauschenbach L, Saban D, Chen B, Darkwah Oppong M, Herten A, Gull HH, Rieβ C, Deuschl C, Schmidt B, Jabbarli R, Wrede KH, Zhu Y, Frank B, Sure U, Dammann P. Multiple cerebral cavernous malformations:clinical course of confirmed, assumed and non-familial disease[J]. Eur J Neurol, 2022, 29:1427-1434. [17] Arkar U, Vipotnik Vesnaver T, Maver A, Perković Benedik M, Peterlin B, Osredkar D. Children with cavernous malformations of the central nervous system[J]. Eur J Paediatr Neurol, 2021, 35:61-66. [18] Bigi S, Capone Mori A, Steinlin M, Remonda L, Landolt H, Boltshauser E. Cavernous malformations of the central nervous system in children:presentation, treatment and outcome of 20 cases[J]. Eur J Paediatr Neurol, 2011, 15:109-116. [19] Josephson CB, Leach JP, Duncan R, Roberts RC, Counsell CE, Al-Shahi Salman R; Scottish Audit of Intracranial Vascular Malformations (SAIVMs) Steering Committee and Collaborators. Seizure risk from cavernous or arteriovenous malformations:prospective population-based study[J]. Neurology, 2011, 76:1548-1554. [20] Akers A, Al- Shahi Salman R, A Awad I, Dahlem K, Flemming K, Hart B, Kim H, Jusue- Torres I, Kondziolka D, Lee C, Morrison L, Rigamonti D, Rebeiz T, Tournier-Lasserve E, Waggoner D, Whitehead K. Synopsis of guidelines for the clinical management of cerebral cavernous malformations:consensus recommendations based on systematic literature review by the angioma alliance scientific advisory board clinical experts panel[J]. Neurosurgery, 2017, 80:665-680. [21] Zheng JJ, Liu PP, Wang L, Zhang LW, Zhang JT, Li D, Wu Z, Wu YM. Natural history of incidentally diagnosed brainstem cavernous malformations in a prospective observational cohort[J]. Neurosurg Rev, 2021, 44:1151-1164. [22] Silva AHD, Wijesinghe H, Lo WB, Walsh AR, Rodrigues D, Solanki GA. Paediatric developmental venous anomalies (DVAs):how often do they bleed and where[J]? Childs Nerv Syst, 2020, 36:1435-1443. [23] Li D, Hao SY, Tang J, Xiao XR, Jia GJ, Wu Z, Zhang LW, Zhang JT. Clinical course of untreated pediatric brainstem cavernous malformations:hemorrhage risk and functional recovery[J]. J Neurosurg Pediatr, 2014, 13:471-483. [24] Hegde AN, Mohan S, Lim CC. CNS cavernous haemangioma:"popcorn" in the brain and spinal cord[J]. Clin Radiol, 2012, 67:380-388. [25] Castillo-Rangel C, Marín G, Hernandez-Contreras KA, Zarate-Calderon C, Vichi-Ramirez MM, Cortez-Saldias W, Rodriguez-Florido MA, Riley-Moguel ÁE, Pichardo O, Torres-Pineda O, Vega-Quesada HG, Lopez-Elizalde R, Ordoñez-Granja J, Alvarado-Martinez HH, Vega-Quesada LA, Aranda-Abreu GE. Atlas of nervous system vascular malformations:a systematic review[J]. Life (Basel), 2022, 12:1199. [26] Feizi P, Lakhani DA, Kataria S, Srivastava S, Tarabishy AR, Deib G, Sriwastava S. Multiple cerebral cavernous hemangiomas masquerading as hemorrhagic brain metastases[J]. Radiol Case Rep, 2020, 15:1973-1977. [27] de Champfleur NM, Langlois C, Ankenbrandt WJ, Le Bars E, Leroy MA, Duffau H, Bonafé A, Jaffe J, Awad IA, Labauge P. Magnetic resonance imaging evaluation of cerebral cavernous malformations with susceptibility-weighted imaging[J]. Neurosurgery, 2011, 68:641-647. [28] Lai PH, Chung HW, Chang HC, Fu JH, Wang PC, Hsu SH, Hsu SS, Lin HS, Chuang TC. Susceptibility -weighted imaging provides complementary value to diffusion-weighted imaging in the differentiation between pyogenic brain abscesses, necrotic glioblastomas, and necrotic metastatic brain tumors[J]. Eur J Radiol, 2019, 117:56-61. [29] Zabramski JM, Wascher TM, Spetzler RF, Johnson B, Golfinos J, Drayer BP, Brown B, Rigamonti D, Brown G. The natural history of familial cavernous malformations:results of an ongoing study[J]. J Neurosurg, 1994, 80:422-432. [30] Nikoubashman O, Di Rocco F, Davagnanam I, Mankad K, Zerah M, Wiesmann M. Prospective hemorrhage rates of cerebral cavernous malformations in children and adolescents based on MRI appearance[J]. AJNR Am J Neuroradiol, 2015, 36:2177-2183. [31] Tournier-Lasserve E. Molecular genetic screening of CCM patients: an overview[J]. Methods Mol Biol, 2020, 2152:49-57. [32] Rath M, Pagenstecher A, Hoischen A, Felbor U. Postzygotic mosaicism in cerebral cavernous malformation[J]. J Med Genet, 2020, 57:212-216. [33] Malinverno M, Maderna C, Abu Taha A, Corada M, Orsenigo F, Valentino M, Pisati F, Fusco C, Graziano P, Giannotta M, Yu QC, Zeng YA, Lampugnani MG, Magnusson PU, Dejana E. Endothelial cell clonal expansion in the development of cerebral cavernous malformations[J]. Nat Commun, 2019, 10:2761. [34] Cardoso C, Arnould M, De Luca C, Otten C, Abdelilah-Seyfried S, Heredia A, Leutenegger AL, Schwaninger M, Tournier-Lasserve E, Boulday G. Novel chronic mouse model of cerebral cavernous malformations[J]. Stroke, 2020, 51:1272-1278. [35] Phillips CM, Stamatovic SM, Keep RF, Andjelkovic AV. Cerebral cavernous malformation pathogenesis:investigating lesion formation and progression with animal models[J]. Int J Mol Sci, 2022, 23:5000. [36] Peyre M, Miyagishima D, Bielle F, Chapon F, Sierant M, Venot Q, Lerond J, Marijon P, Abi-Jaoude S, Le Van T, Labreche K, Houlston R, Faisant M, Clémenceau S, Boch AL, Nouet A, Carpentier A, Boetto J, Louvi A, Kalamarides M. Somatic PIK3CA mutations in sporadic cerebral cavernous malformations[J]. N Engl J Med, 2021, 385:996-1004. [37] Abou-Fadel J, Smith M, Falahati K, Zhang J. Comparative omics of CCM signaling complex (CSC)[J]. Chin Neurosurg J, 2020, 6:4. [38] Su VL, Calderwood DA. Signalling through cerebral cavernous malformation protein networks[J]. Open Biol, 2020, 10:200263. [39] Chung MW, Chuang CC, Wang CC, Chen HC, Hsu PW. Prognostic factors analysis for intracranial cavernous malformations treated with linear accelerator stereotactic radiosurgery[J]. Life (Basel), 2022, 12:1363. [40] Patet G, Bartoli A, Meling TR. Natural history and treatment options of radiation-induced brain cavernomas:a systematic review[J]. Neurosurg Rev, 2022, 45:243-251. [41] Snellings DA, Hong CC, Ren AA, Lopez-Ramirez MA, Girard R, Srinath A, Marchuk DA, Ginsberg MH, Awad IA, Kahn ML. Cerebral cavernous malformation:from mechanism to therapy[J]. Circ Res, 2021, 129:195-215. [42] Bubenikova A, Skalicky P, Benes V Jr, Benes V Sr, Bradac O. Overview of cerebral cavernous malformations:comparison of treatment approaches[J]. J Neurol Neurosurg Psychiatry, 2022, 93:475-480. [43] Fontanella MM, Agosti E, Zanin L, di Bergamo LT, Doglietto F. Cerebral cavernous malformation remnants after surgery:a single- center series with long-term bleeding risk analysis[J]. Neurosurg Rev, 2021, 44:2639-2645. [44] Hashikata H, Maki Y, Ishibashi R, Goto M, Toda H. Infratentorial developmental venous anomaly concurrent with a cavernoma and dural arteriovenous fistula[J]. J Stroke Cerebrovasc Dis, 2022, 31:106608. [45] El Allouchi Y, Hamadi H, Benantar L, Aniba K. Management of central nervous system cavernomas:an experience of the department of neurosurgery at the Ibn Tofail Hospital, Mohammed Ⅵ University Hospital[J]. Cureus, 2022, 14:e33028. [46] Harris L, Poorthuis MHF, Grover P, Kitchen N, Al-Shahi Salman R. Surgery for cerebral cavernous malformations:a systematic review and meta-analysis[J]. Neurosurg Rev, 2022, 45:231-241. [47] Poorthuis MHF, Rinkel LA, Lammy S, Al-Shahi Salman R. Stereotactic radiosurgery for cerebral cavernous malformations:a systematic review[J]. Neurology, 2019, 93:e1971-1979. [48] Flemming KD, Lanzino G. Stereotactic radiosurgery for cavernous malformations:natural history or treatment effect[J]? Neurology, 2019, 93:921-922. [49] Rinkel LA, Al-Shahi Salman R, Rinkel GJ, Greving JP. Radiosurgical, neurosurgical, or no intervention for cerebral cavernous malformations:a decision analysis[J]. Int J Stroke, 2019, 14:939-945. |